<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Chronic myelomonocytic leukemia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Chronic_myelomonocytic_leukemia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Chronic_myelomonocytic_leukemia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Chronic_myelomonocytic_leukemia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Chronic_myelomonocytic_leukemia","wgTitle":"Chronic myelomonocytic leukemia","wgCurRevisionId":668628283,"wgRevisionId":668628283,"wgArticleId":8072180,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with contributors link","Articles that use a Medicine navs subtemplate","Chronic myeloid leukemia"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Chronic_myelomonocytic_leukemia","wgRelevantArticleId":8072180,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/4/47/CMML.jpg/100px-CMML.jpg","wgULSAcceptLanguageList":["en-us"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q1088072"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Chronic_myelomonocytic_leukemia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Chronic myelomonocytic leukemia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Chronic myelomonocytic leukaemia</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:CMML.jpg" class="image"><img alt="CMML.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/47/CMML.jpg/230px-CMML.jpg" width="230" height="173" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/47/CMML.jpg/345px-CMML.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/47/CMML.jpg/460px-CMML.jpg 2x" data-file-width="2560" data-file-height="1920" /></a>
<div>Peripheral blood film of CMML. Monocytosis and the presence of myelocytes, metamyelocytes and promyelocytes is typical of CMML.</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Hematology" title="Hematology">Hematology</a> and <a href="/wiki/Oncology" title="Oncology">oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=205.1">205.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></th>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I99453/">9945/3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D015477">D015477</a></td>
</tr>
</table>
<p><b>Chronic myelomonocytic leukaemia</b> (CMML) is a type of <a href="/wiki/Leukaemia" title="Leukaemia" class="mw-redirect">leukaemia</a>, which are <a href="/wiki/Cancer" title="Cancer">cancers</a> of the blood-forming cells of the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a>. In adults, blood cells are formed in the bone marrow, by a process that is known as <a href="/wiki/Haematopoiesis" title="Haematopoiesis">haematopoiesis</a>. In CMML, there are increased numbers of <a href="/wiki/Monocytes" title="Monocytes" class="mw-redirect">monocytes</a> and immature blood cells (<a href="/wiki/Precursor_cell" title="Precursor cell">blasts</a>) in the peripheral blood and bone marrow, as well as abnormal looking cells (<a href="/wiki/Dysplasia" title="Dysplasia">dysplasia</a>) in at least one type of blood cell.<sup id="cite_ref-pmid19605822_1-0" class="reference"><a href="#cite_note-pmid19605822-1"><span>[</span>1<span>]</span></a></sup> CMML shows characteristics of a <a href="/wiki/Myelodysplastic_syndrome" title="Myelodysplastic syndrome">myelodysplastic syndrome</a> (MDS); a disorder that produces abnormal looking blood cells, and a <a href="/wiki/Myeloproliferative_disorder" title="Myeloproliferative disorder" class="mw-redirect">myeloproliferative disorder</a> (MPD); a disorder characterised by the overproduction of blood cells. For this reason CMML was reclassified as a MDS/MPN overlap disorder in 2002.<sup id="cite_ref-pmid12239137_2-0" class="reference"><a href="#cite_note-pmid12239137-2"><span>[</span>2<span>]</span></a></sup> For a diagnosis of CMML, the <a href="/wiki/World_Health_Organisation" title="World Health Organisation" class="mw-redirect">World Health Organisation</a> (WHO) states that the blood monocyte count must be &gt;1x10<sup>9</sup>/L, no Philadelphia chromosome or mutations in the <a href="/wiki/PDGFRA" title="PDGFRA">PDGFRA</a> or <a href="/wiki/PDGFRB" title="PDGFRB">PDGFRB</a> gene should be present, the blast count must be &lt;20% and dysplasia of at least one lineage of myeloid blood cell should be present.<sup id="cite_ref-pmid22160042_3-0" class="reference"><a href="#cite_note-pmid22160042-3"><span>[</span>3<span>]</span></a></sup> Azacitidine is a drug used to treat CMML and is approved by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) and the <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a>. <a href="/wiki/Stem_cell_transplant" title="Stem cell transplant" class="mw-redirect">Stem cell transplant</a> is also used to treat CMML, and involves the transplantation of donor <a href="/wiki/Haematopoietic_stem_cell" title="Haematopoietic stem cell" class="mw-redirect">haematopoietic stem cells</a> into the recipient. <a href="/wiki/Blood_transfusion" title="Blood transfusion">Blood transfusion</a> and <a href="/wiki/Erythropoietin" title="Erythropoietin">erythropoietin</a> are used to treat disease associated anaemia.<sup id="cite_ref-pmid20856790_4-0" class="reference"><a href="#cite_note-pmid20856790-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Soiffer2008_5-0" class="reference"><a href="#cite_note-Soiffer2008-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-pmid12057067_6-0" class="reference"><a href="#cite_note-pmid12057067-6"><span>[</span>6<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#FAB_classification"><span class="tocnumber">1.1</span> <span class="toctext">FAB classification</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#WHO_classification"><span class="tocnumber">1.2</span> <span class="toctext">WHO classification</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#Epidemiology"><span class="tocnumber">2</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Etiology"><span class="tocnumber">3</span> <span class="toctext">Etiology</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Symptoms"><span class="tocnumber">4</span> <span class="toctext">Symptoms</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Clinical_features"><span class="tocnumber">5</span> <span class="toctext">Clinical features</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Diagnosis"><span class="tocnumber">6</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#FAB"><span class="tocnumber">6.1</span> <span class="toctext">FAB</span></a>
<ul>
<li class="toclevel-3 tocsection-10"><a href="#FAB_subtypes"><span class="tocnumber">6.1.1</span> <span class="toctext">FAB subtypes</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-11"><a href="#WHO"><span class="tocnumber">6.2</span> <span class="toctext">WHO</span></a>
<ul>
<li class="toclevel-3 tocsection-12"><a href="#WHO_subtypes"><span class="tocnumber">6.2.1</span> <span class="toctext">WHO subtypes</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Cytogenetic_abnormalities_and_genetic_mutations"><span class="tocnumber">7</span> <span class="toctext">Cytogenetic abnormalities and genetic mutations</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Pathogenesis"><span class="tocnumber">8</span> <span class="toctext">Pathogenesis</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Prognosis"><span class="tocnumber">9</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Factors_affecting_prognosis"><span class="tocnumber">9.1</span> <span class="toctext">Factors affecting prognosis</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Scoring_systems"><span class="tocnumber">9.2</span> <span class="toctext">Scoring systems</span></a>
<ul>
<li class="toclevel-3 tocsection-18"><a href="#IPSS"><span class="tocnumber">9.2.1</span> <span class="toctext">IPSS</span></a></li>
<li class="toclevel-3 tocsection-19"><a href="#MD_Anderson_Prognostic_Scoring_System"><span class="tocnumber">9.2.2</span> <span class="toctext">MD Anderson Prognostic Scoring System</span></a></li>
<li class="toclevel-3 tocsection-20"><a href="#The_D.C3.BCsseldorf_score"><span class="tocnumber">9.2.3</span> <span class="toctext">The Düsseldorf score</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-21"><a href="#Treatment"><span class="tocnumber">10</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-22"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Hematopoiesis_(human)_diagram.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/69/Hematopoiesis_%28human%29_diagram.png/220px-Hematopoiesis_%28human%29_diagram.png" width="220" height="144" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/69/Hematopoiesis_%28human%29_diagram.png/330px-Hematopoiesis_%28human%29_diagram.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/69/Hematopoiesis_%28human%29_diagram.png/440px-Hematopoiesis_%28human%29_diagram.png 2x" data-file-width="1929" data-file-height="1267" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Hematopoiesis_(human)_diagram.png" class="internal" title="Enlarge"></a></div>
Haematopoiesis. The two lineages of myeloid and lymphoid cells are formed from haematopoietic stem cells.</div>
</div>
</div>
<p>Leukaemia subtypes are categorised into single clinical entities so that they can be diagnosed and treated appropriately. Leukaemias are subdivided into <a href="/wiki/Lymphoid" title="Lymphoid" class="mw-redirect">lymphoid</a> and <a href="/wiki/Myeloid" title="Myeloid">myeloid</a> neoplasms, depending on which bone marrow cells are cancerous. The myeloid neoplasms contain acute and chronic leukaemias, myelodysplastic syndromes (MDSs) and myeloproliferative neoplasms (MPNs). MPNs are characterised by increased production of myeloid blood cells, with a higher than normal number of mature cells. Unlike MPNs, MDSs have a dysfunctional production of myeloid cells with a reduced number of mature cells. Many of the cells produced in MDS are abnormal looking, known as dysplasia. CMML shows characteristics of both groups and thus is a difficult disease to categorise.<sup id="cite_ref-isbn4051_7-0" class="reference"><a href="#cite_note-isbn4051-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-pmid20699489_8-0" class="reference"><a href="#cite_note-pmid20699489-8"><span>[</span>8<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="FAB_classification">FAB classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=2" title="Edit section: FAB classification">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/French-American-British_classification" title="French-American-British classification" class="mw-redirect">French-American-British</a> (FAB) classification system was published in 1976 to classify the leukaemias. It placed CMML into the category of MDS, along with the refractory anaemia, refractory anaemia with ring sideroblasts, refractory anaemia with excess blasts and refractory anaemia with excess blasts in transformation. The system does have clinical utility; however factors such as cytogenetic status are not within the remit of the classification. For this reason, many disease entities in these groups show a great deal of heterogeneity.<sup id="cite_ref-pmid20699489_8-1" class="reference"><a href="#cite_note-pmid20699489-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-isbn85623_9-0" class="reference"><a href="#cite_note-isbn85623-9"><span>[</span>9<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="WHO_classification">WHO classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=3" title="Edit section: WHO classification">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2001 the WHO Classification of Myeloid Neoplasms was published, classifying CMML into a new group of diseases, the myelodysplastic/myeloproliferative neoplasms (MDS/MPN), reflecting the disease's neoplastic nature. Other diseases in this category are <a href="/wiki/JMML" title="JMML" class="mw-redirect">juvenile myelomonocytic leukaemia</a>, atypical CML; BCR-ABL1 negative and MDS/MPD unclassifiable. These MDS/MPN overlap syndromes have effective production of some lineages of blood cells, but show ineffective proliferation of other lineages. The 2008 revision of the classification moved cases of CMML with PDGFR gene translocations to a new group, myeloid/lymphoid neoplasms with eosinophilia with abnormalities of <a href="/wiki/PDGFRA" title="PDGFRA">PDGFRA</a>, <a href="/wiki/PDGFRB" title="PDGFRB">PDGFRB</a> or <a href="/wiki/FGFR1" title="FGFR1" class="mw-redirect">FGFR1</a>.<sup id="cite_ref-pmid12239137_2-1" class="reference"><a href="#cite_note-pmid12239137-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-isbn4051_7-1" class="reference"><a href="#cite_note-isbn4051-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-isbn0123744199_10-0" class="reference"><a href="#cite_note-isbn0123744199-10"><span>[</span>10<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=4" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There have been few individual <a href="/wiki/Epidemiology" title="Epidemiology">epidemiological</a> studies of CMML, due to the difficulty in the disease classification. CMML has an estimated incidence of less than 1 per 100,000 persons per year.<sup id="cite_ref-pmid22160044_11-0" class="reference"><a href="#cite_note-pmid22160044-11"><span>[</span>11<span>]</span></a></sup> The median age of diagnosis is 65–75. CMML has a propensity for males rather than females, at a ratio of 1.5–3:1.<sup id="cite_ref-isbn2411_12-0" class="reference"><a href="#cite_note-isbn2411-12"><span>[</span>12<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Etiology">Etiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=5" title="Edit section: Etiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Although the <a href="/wiki/Aetiology" title="Aetiology" class="mw-redirect">aetiology</a> of CMML is unknown, environmental carcinogens, ionising radiation and cytotoxic agents may have a role in causing disease.<sup id="cite_ref-isbn2411_12-1" class="reference"><a href="#cite_note-isbn2411-12"><span>[</span>12<span>]</span></a></sup> Approximately one third of cases of MDS with a monocyte count of &gt;10% and &lt;1x10<sup>9</sup>/L will progress to CMML.<sup id="cite_ref-isbn79891_13-0" class="reference"><a href="#cite_note-isbn79891-13"><span>[</span>13<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Symptoms">Symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=6" title="Edit section: Symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>One of the most common symptoms of CMML is splenomegaly, found in approximately half of cases. Other less frequent symptoms consist of <a href="/wiki/Anaemia" title="Anaemia" class="mw-redirect">anaemia</a>, <a href="/wiki/Fever" title="Fever">fever</a>, <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a>, <a href="/wiki/Night_sweats" title="Night sweats">night sweats</a>, <a href="/wiki/Infection" title="Infection">infection</a>, <a href="/wiki/Bleeding" title="Bleeding">bleeding</a>, <a href="/wiki/Synovitis" title="Synovitis">synovitis</a>, <a href="/wiki/Lymphadenopathy" title="Lymphadenopathy">lymphadenopathy</a>, skin rashes, <a href="/wiki/Pleural_effusion" title="Pleural effusion">pleural effusion</a>, <a href="/wiki/Pericardial_effusion" title="Pericardial effusion">pericardial effusion</a> and <a href="/wiki/Peritoneal_effusion" title="Peritoneal effusion" class="mw-redirect">peritoneal effusion</a>.<sup id="cite_ref-isbn4051_7-2" class="reference"><a href="#cite_note-isbn4051-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-isbn2411_12-2" class="reference"><a href="#cite_note-isbn2411-12"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-isbn9890_14-0" class="reference"><a href="#cite_note-isbn9890-14"><span>[</span>14<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Clinical_features">Clinical features</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=7" title="Edit section: Clinical features">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Blood_film" title="Blood film">Blood films</a> display a range of abnormalities. A monocyte count of &gt;1x10<sup>9</sup>/L is essential for a diagnosis of CMML. Other features may include; leukocytosis (50% of cases); left shift and dysplasia of monocytes and granulocytes; presence of metamyelocytes, <a href="/wiki/Myelocytes" title="Myelocytes" class="mw-redirect">myelocytes</a> and <a href="/wiki/Promonocytes" title="Promonocytes" class="mw-redirect">promonocytes</a>; monocytes with hypersegmented/abnormal shaped nuclei, increased cytoplasmic basophilia and/or the presence of cytoplasmic granules; eosinophilia (in cases of CMML with eosinophilia); and spherocytosis (in cases of DCT positive haemolytic anaemia). Platelet counts may be reduced, increased or normal.<sup id="cite_ref-isbn4051_7-3" class="reference"><a href="#cite_note-isbn4051-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-isbn7817_15-0" class="reference"><a href="#cite_note-isbn7817-15"><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-isbn370607_16-0" class="reference"><a href="#cite_note-isbn370607-16"><span>[</span>16<span>]</span></a></sup> Haemoglobin levels are usually reduced with normocytic and normochromic red blood cells. <a href="/wiki/Autoantibodies" title="Autoantibodies" class="mw-redirect">Autoantibodies</a> and <a href="/wiki/Cold_agglutinins" title="Cold agglutinins" class="mw-redirect">cold agglutinins</a> may be present and 10% of CMML is <a href="/wiki/Coombs_test" title="Coombs test">DCT</a> positive.<sup id="cite_ref-isbn4051_7-4" class="reference"><a href="#cite_note-isbn4051-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-isbn9890_14-1" class="reference"><a href="#cite_note-isbn9890-14"><span>[</span>14<span>]</span></a></sup> <a href="/wiki/Bone_marrow_aspirate" title="Bone marrow aspirate" class="mw-redirect">Bone marrow aspirates</a> will display hypercellularity with increased counts of granulocytic and monocytic cells.<sup id="cite_ref-pmid19605822_1-1" class="reference"><a href="#cite_note-pmid19605822-1"><span>[</span>1<span>]</span></a></sup> Bone marrow core biopsies may show a predominance of myelocytic and monocytic cells, abnormal localisation of immature precursors and dysplastic <a href="/wiki/Megakaryocyte" title="Megakaryocyte">megakaryocytes</a>.<sup id="cite_ref-pmid19605822_1-2" class="reference"><a href="#cite_note-pmid19605822-1"><span>[</span>1<span>]</span></a></sup> Monocytic nodules are a common feature in biopsies.<sup id="cite_ref-isbn370607_16-1" class="reference"><a href="#cite_note-isbn370607-16"><span>[</span>16<span>]</span></a></sup></p>
<p>The phenotypical characteristics of CMML are; <a href="/wiki/CD11b" title="CD11b" class="mw-redirect">CD11b</a>, <a href="/wiki/CD11c" title="CD11c">CD11c</a>, <a href="/wiki/CD14" title="CD14">CD14</a>, <a href="/wiki/CD33" title="CD33">CD33</a>, <a href="/wiki/CD45" title="CD45" class="mw-redirect">CD45</a> and <a href="/wiki/CD64_(biology)" title="CD64 (biology)">CD64</a> seen in 100% of cases; <a href="/wiki/CD13" title="CD13" class="mw-redirect">CD13</a> found in 95% of cases; <a href="/wiki/CD4" title="CD4">CD4</a> found in 76% of cases; <a href="/wiki/HLA-DR" title="HLA-DR">HLA-DR</a> found in 71% of cases; <a href="/wiki/CD56" title="CD56" class="mw-redirect">CD56</a> found in 53% of cases; <a href="/wiki/CD2" title="CD2">CD2</a> found in 34% of cases; <a href="/wiki/CD16" title="CD16">CD16</a> found in 29% of cases; <a href="/wiki/CD10" title="CD10" class="mw-redirect">CD10</a> found in 28% of cases; <a href="/wiki/CD23" title="CD23">CD23</a> and <a href="/wiki/CD7" title="CD7">CD7</a> found in 9% of cases; and <a href="/wiki/CD117" title="CD117">CD117</a> found in 5% of cases.<sup id="cite_ref-isbn84214_17-0" class="reference"><a href="#cite_note-isbn84214-17"><span>[</span>17<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=8" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="FAB">FAB</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=9" title="Edit section: FAB">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The FAB criteria for diagnosis are as follows:<sup id="cite_ref-pmid6952920_18-0" class="reference"><a href="#cite_note-pmid6952920-18"><span>[</span>18<span>]</span></a></sup></p>
<ul>
<li>Monocyte count &gt;1x10<sup>9</sup>/L</li>
<li>0–19% blasts in bone marrow</li>
<li>&lt;5% blasts in peripheral blood</li>
</ul>
<h4><span class="mw-headline" id="FAB_subtypes">FAB subtypes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=10" title="Edit section: FAB subtypes">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The FAB also arbitrarily categorises CMML into myelodysplastic-like and myeloproliferative-like groups. A white blood count of 13x10<sup>9</sup> is used as a cut-off to differentiate the two.<sup id="cite_ref-pmid22160044_11-1" class="reference"><a href="#cite_note-pmid22160044-11"><span>[</span>11<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="WHO">WHO</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=11" title="Edit section: WHO">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The WHO criteria for diagnosis are as follows:<sup id="cite_ref-pmid22160042_3-1" class="reference"><a href="#cite_note-pmid22160042-3"><span>[</span>3<span>]</span></a></sup></p>
<ul>
<li>Persistent peripheral blood <a href="/wiki/Monocytosis" title="Monocytosis">monocytosis</a> with counts &gt;1x10<sup>9</sup>/L</li>
<li>No Philadelphia chromosome or <a href="/wiki/BCR-ABL" title="BCR-ABL" class="mw-redirect">BCR-ABL</a>1 fusion gene</li>
<li>No rearrangement of <a href="/wiki/PDGFRA" title="PDGFRA">PDGFRA</a> or <a href="/wiki/PDGFRB" title="PDGFRB">PDGFRB</a> gene</li>
<li>&lt;20% myeloblasts, monoblasts and promonocytes in peripheral blood or bone marrow</li>
<li>Dysplasia in one or more of the myeloid lineages; if myelodysplasia is absent or minimal then a diagnosis of CMML can be made if other requirements are met and:
<ul>
<li>A molecular genetic abnormality is present in haematopoietic cells, or</li>
<li>Monocytosis present for ≥3 months and other causes of monocytosis have been ruled out</li>
</ul>
</li>
</ul>
<h4><span class="mw-headline" id="WHO_subtypes">WHO subtypes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=12" title="Edit section: WHO subtypes">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>WHO defined CMML has two main subsets, CMML-1 and CMML-2. CMML-1 is diagnosed if <a href="/wiki/Myeloblasts" title="Myeloblasts" class="mw-redirect">myeloblasts</a>, <a href="/wiki/Monoblasts" title="Monoblasts" class="mw-redirect">monoblasts</a> and <a href="/wiki/Promonocytes" title="Promonocytes" class="mw-redirect">promonocytes</a> are &lt;5% of peripheral blood and &lt;10% of bone marrow. CMML-2 is diagnosed if:</p>
<ul>
<li>Myeloblasts, monoblasts or promonocytes are 5-19% in blood, or</li>
<li>Myeloblasts, monoblasts or promonocytes are 10-19% in bone marrow, or</li>
<li>Auer rods are present</li>
</ul>
<p>CMML-1 and CMML-2 can be additionally grouped as CMML-1 or CMML-2 with eosinophilia. These are diagnosed if the above criteria are met and the blood eosinophil count is &gt;1.5x10<sup>9</sup>/L.<sup id="cite_ref-isbn2411_12-3" class="reference"><a href="#cite_note-isbn2411-12"><span>[</span>12<span>]</span></a></sup></p>
<p>Presence of two or more phenotypical abnormalities can aid a diagnosis of CMML in the absence of identifying cytogenetic or dysplastic features. These can include the expression of CD56 and/or CD2, or under-expression of HLA-DR.<sup id="cite_ref-pmid22160042_3-2" class="reference"><a href="#cite_note-pmid22160042-3"><span>[</span>3<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Cytogenetic_abnormalities_and_genetic_mutations">Cytogenetic abnormalities and genetic mutations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=13" title="Edit section: Cytogenetic abnormalities and genetic mutations">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Clonal genetic abnormalities are common in CMML but they are not specific for diagnosis of the disease. The most common found are the 8+, −7/del (7q) and structural 12p abnormalities.<sup id="cite_ref-isbn2411_12-4" class="reference"><a href="#cite_note-isbn2411-12"><span>[</span>12<span>]</span></a></sup> <a href="/wiki/KRAS" title="KRAS">KRAS</a> and <a href="/wiki/Neuroblastoma_RAS_viral_oncogene_homolog" title="Neuroblastoma RAS viral oncogene homolog">NRAS</a> are mutated in 25–40% of the cases of CMML. The <a href="/wiki/Jak2" title="Jak2" class="mw-redirect">Jak2</a> V617F mutation is found in 10% of cases. Mutations in transcription factors such as <a href="/wiki/RUNX1" title="RUNX1">RUNX1</a>, <a href="/wiki/CEBPA" title="CEBPA">CEBPA</a>, <a href="/wiki/NPM1" title="NPM1">NPM1</a> and <a href="/wiki/WT1" title="WT1">WT1</a> have been found in up to 30% of cases. Mutations of <a href="/wiki/Cbl_gene" title="Cbl gene" class="mw-redirect">CBL</a> are found in approximately 5–18% of cases.<sup id="cite_ref-pmid22160042_3-3" class="reference"><a href="#cite_note-pmid22160042-3"><span>[</span>3<span>]</span></a></sup> Mutations in the <a href="/wiki/TET2" title="TET2" class="mw-redirect">TET2</a> gene are found in approximately 40–50% of CMML.<sup id="cite_ref-pmid22160044_11-2" class="reference"><a href="#cite_note-pmid22160044-11"><span>[</span>11<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathogenesis">Pathogenesis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=14" title="Edit section: Pathogenesis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>With a high rate of Ras mutation in CMML, deregulation of this signalling pathway has been linked to the pathogenesis of the disease. <a href="/wiki/Tumor_necrosis_factor" title="Tumor necrosis factor" class="mw-redirect">Tumour necrosis factor</a>, <a href="/wiki/GM-CSF" title="GM-CSF" class="mw-redirect">GM-CSF</a>, <a href="/wiki/Interleukin-3" title="Interleukin-3" class="mw-redirect">interleukin-3</a>, <a href="/wiki/Interleukin-4" title="Interleukin-4" class="mw-redirect">interleukin-4</a>, <a href="/wiki/Interleukin-6" title="Interleukin-6" class="mw-redirect">interleukin-6</a>, and <a href="/wiki/Interleukin-10" title="Interleukin-10" class="mw-redirect">interleukin-10</a> may have a role in hyperproliferative CMML cells. These cytokines can stimulate the growth of CMML <i>in vitro</i>.<sup id="cite_ref-pmid12446429_19-0" class="reference"><a href="#cite_note-pmid12446429-19"><span>[</span>19<span>]</span></a></sup> Hypermethylation of cytosine residues (usually in the promoter regions of genes) occurs in many malignancies to regulate gene expression. One commonly hypermethylated gene in CMML is <a href="/wiki/CDKN2B" title="CDKN2B">p15<sup>INK4b</sup></a>, a gene involved in cell cycle regulation.<sup id="cite_ref-pmid20856790_4-1" class="reference"><a href="#cite_note-pmid20856790-4"><span>[</span>4<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=15" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Factors_affecting_prognosis">Factors affecting prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=16" title="Edit section: Factors affecting prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>CMML-2 has a reduced overall survival as compared with CMML-1, with median survivals of 15 and 20 months, respectively. Myeloproliferative CMML (&gt;13x10<sup>9</sup> monocytes/L) has a reduced survival compared with myelodysplastic CMML. A platelet count of &lt;100 x10<sup>9</sup>/L reduces overall survival. A haemoglobin level of &lt;10g/dL has a reduced overall survival. Some cytogenetic abnormalities have implications on the prognosis of CMML. Normal karyotypes or the single loss of the Y chromosome have low risk prognoses. Trisomy 8, chromosome 7 abnormalities and complex karyotypes comprise a high risk group. Other cytogenetic abnormalities have intermediate prognoses. Somatic mutations in genes such as <a href="/wiki/ASXL1" title="ASXL1">ASXL1</a> and <a href="/wiki/EZH2" title="EZH2">EZH2</a> are associated with poor prognosis.<sup id="cite_ref-pmid22160044_11-3" class="reference"><a href="#cite_note-pmid22160044-11"><span>[</span>11<span>]</span></a></sup></p>
<p>CMML has a 20-30% chance of transformation to AML, a lower rate than other similar diseases. The CMML-2 subtype is associated with increased risk of transformation and ASXL1 and RUNX1 mutations also increase the risk of transition to AML.<sup id="cite_ref-pmid22160044_11-4" class="reference"><a href="#cite_note-pmid22160044-11"><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-FinnPeterson2004_20-0" class="reference"><a href="#cite_note-FinnPeterson2004-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-Bain2003_21-0" class="reference"><a href="#cite_note-Bain2003-21"><span>[</span>21<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Scoring_systems">Scoring systems</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=17" title="Edit section: Scoring systems">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="IPSS">IPSS</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=18" title="Edit section: IPSS">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The <a href="/wiki/International_Prognostic_Scoring_System" title="International Prognostic Scoring System">International Prognostic Scoring System</a> (IPSS) was developed in the mid-1990s to assess the prognosis of MDS patients. This system stratifies cases into 2 groups; a lower-risk group (sub divided into low and intermediate-1) and a higher risk (subdivided into intermediate-2 and high). It uses the blast percentage, number of cytopaenias and bone marrow cytogenetics data to place cases of CMML into these groups. Due to the scoring system being developed for MDS, the more myeloproliferative cases of CMML (WBC &gt;13x10<sup>9</sup>) are excluded from the scoring system. Although the IPSS scoring system is used clinically, there is a high variability in each group. For this reason, new modalities for assessing prognosis in MDS (and CMML) are being developed.<sup id="cite_ref-pmid22160044_11-5" class="reference"><a href="#cite_note-pmid22160044-11"><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-pmid9058730_22-0" class="reference"><a href="#cite_note-pmid9058730-22"><span>[</span>22<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="MD_Anderson_Prognostic_Scoring_System">MD Anderson Prognostic Scoring System</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=19" title="Edit section: MD Anderson Prognostic Scoring System">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>A new method developed using data from the M.D Anderson Cancer Center found that a haemoglobin level of &lt;12g/dL, total circulating lymphocyte count of &gt;2.5 x 10<sup>9</sup>/L, &gt;0% immature myeloid cells, &gt;10% bone marrow blasts causes a reduced overall survival. This data allows cases of CMML to be stratified into low, intermediate-1, intermediate-2 and high risk groups. These groups have median survival times of 24, 15, 8 and 5 months respectively.<sup id="cite_ref-pmid21239815_23-0" class="reference"><a href="#cite_note-pmid21239815-23"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-pmid11806985_24-0" class="reference"><a href="#cite_note-pmid11806985-24"><span>[</span>24<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="The_D.C3.BCsseldorf_score">The Düsseldorf score</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=20" title="Edit section: The Düsseldorf score">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The Düsseldorf score stratifies cases using four categories, giving one point for each; bone marrow blasts ≥5%, LDH &gt;200U/L, haemoglobin ≤9g/dL and a platelet count ≤100,000/uL. A score of 0 indicates a low risk group' 1-2 indicates an intermediate risk group and 3-4 indicates a high risk group. The cumulative 2 year survival of scores 0, 1-2 and 3-4 is 91%, 52% and 9%; and risk of AML transformation is 0%, 19% and 54% respectively.<sup id="cite_ref-isbn79891_13-1" class="reference"><a href="#cite_note-isbn79891-13"><span>[</span>13<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=21" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The treatment of CMML remains challenging due to the lack of clinical trials investigating the disease as its own clinical entity. It is often grouped with MDS in clinical trials, and for this reason the treatment of CMML is very similar to that of MDS. Most cases are dealt with as supportive rather than curative because most therapies do not effectively increase survival. Indications for treatment include the presence of B symptoms, symptomatic organ involvement, increasing blood counts, hyperleukocytosis, <a href="/wiki/Leukostasis" title="Leukostasis">leukostasis</a> and/or worsening <a href="/wiki/Cytopenia" title="Cytopenia">cytopaenias</a>.<sup id="cite_ref-pmid12057067_6-1" class="reference"><a href="#cite_note-pmid12057067-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-isbn79891_13-2" class="reference"><a href="#cite_note-isbn79891-13"><span>[</span>13<span>]</span></a></sup></p>
<p><a href="/wiki/Blood_transfusion" title="Blood transfusion">Blood transfusions</a> and <a href="/wiki/Erythropoietin" title="Erythropoietin">EPO</a> administration are used to raise haemoglobin levels in cases with anaemia.<sup id="cite_ref-pmid12057067_6-2" class="reference"><a href="#cite_note-pmid12057067-6"><span>[</span>6<span>]</span></a></sup></p>
<p><a href="/wiki/Azacitidine" title="Azacitidine">Azacitidine</a> is a drug approved by the US <a href="/wiki/Food_%26_Drug_Administration" title="Food &amp; Drug Administration" class="mw-redirect">Food &amp; Drug Administration</a> (FDA) for the treatment of CMML and by the <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> for high risk non-proliferative CMML with 10-19% marrow blasts. It is a cytidine analogue that causes hypomethylation of DNA by inhibition of DNA methyltransferase. <a href="/wiki/Decitabine" title="Decitabine">Decitabine</a> is a similar drug to azacitidine and is approved by the FDA for treatments of all subtypes of MDS, including CMML. Hydroxyurea is a chemotherapy that is used in the myeloproliferative form of CMML to reduce cell numbers.<sup id="cite_ref-pmid20856790_4-2" class="reference"><a href="#cite_note-pmid20856790-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-pmid22160044_11-6" class="reference"><a href="#cite_note-pmid22160044-11"><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-isbn79891_13-3" class="reference"><a href="#cite_note-isbn79891-13"><span>[</span>13<span>]</span></a></sup></p>
<p><a href="/wiki/Hematopoietic_stem_cell_transplant" title="Hematopoietic stem cell transplant" class="mw-redirect">Haematopoietic stem cell transplant</a> remains the only curative treatment for CMML. However, due to the late age of onset and presence of other illnesses, this form of treatment is often not possible.<sup id="cite_ref-Soiffer2008_5-1" class="reference"><a href="#cite_note-Soiffer2008-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-pmid21401573_25-0" class="reference"><a href="#cite_note-pmid21401573-25"><span>[</span>25<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit&amp;section=22" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-pmid19605822-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19605822_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19605822_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid19605822_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Foucar K (August 2009). "Myelodysplastic/myeloproliferative neoplasms". <i>Am. J. Clin. Pathol.</i> <b>132</b> (2): 281–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1309%2FAJCPJ71PTVIKGEVT">10.1309/AJCPJ71PTVIKGEVT</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19605822">19605822</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Myelodysplastic%2Fmyeloproliferative+neoplasms&amp;rft.au=Foucar+K&amp;rft.aulast=Foucar+K&amp;rft.date=August+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1309%2FAJCPJ71PTVIKGEVT&amp;rft_id=info%3Apmid%2F19605822&amp;rft.issue=2&amp;rft.jtitle=Am.+J.+Clin.+Pathol.&amp;rft.pages=281-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=132" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12239137-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid12239137_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12239137_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Vardiman JW, Harris NL, Brunning RD (October 2002). "The World Health Organization (WHO) classification of the myeloid neoplasms". <i>Blood</i> <b>100</b> (7): 2292–302. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2002-04-1199">10.1182/blood-2002-04-1199</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12239137">12239137</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=The+World+Health+Organization+%28WHO%29+classification+of+the+myeloid+neoplasms&amp;rft.aulast=Vardiman+JW%2C+Harris+NL%2C+Brunning+RD&amp;rft.au=Vardiman+JW%2C+Harris+NL%2C+Brunning+RD&amp;rft.date=October+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2002-04-1199&amp;rft_id=info%3Apmid%2F12239137&amp;rft.issue=7&amp;rft.jtitle=Blood&amp;rft.pages=2292-302&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=100" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid22160042-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22160042_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22160042_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid22160042_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid22160042_3-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Vardiman J, Hyjek E (2011). "World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants". <i>HematologyAmSocHematolEducProgram</i> <b>2011</b>: 250–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fasheducation-2011.1.250">10.1182/asheducation-2011.1.250</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22160042">22160042</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=World+health+organization+classification%2C+evaluation%2C+and+genetics+of+the+myeloproliferative+neoplasm+variants&amp;rft.aulast=Vardiman+J%2C+Hyjek+E&amp;rft.au=Vardiman+J%2C+Hyjek+E&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2011.1.250&amp;rft_id=info%3Apmid%2F22160042&amp;rft.jtitle=HematologyAmSocHematolEducProgram&amp;rft.pages=250-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2011" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20856790-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20856790_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20856790_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20856790_4-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">McCormack, SE; Warlick, ED (Sep 7, 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2939768">"Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine"</a>. <i>OncoTargets and therapy</i> <b>3</b>: 157–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2147%2FOTT.S5852">10.2147/OTT.S5852</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2939768">2939768</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20856790">20856790</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Epigenetic+approaches+in+the+treatment+of+myelodysplastic+syndromes%3A+clinical+utility+of+azacitidine&amp;rft.aufirst=SE&amp;rft.aulast=McCormack&amp;rft.au=McCormack%2C+SE&amp;rft.au=Warlick%2C+ED&amp;rft.date=Sep+7%2C+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2939768&amp;rft_id=info%3Adoi%2F10.2147%2FOTT.S5852&amp;rft_id=info%3Apmc%2F2939768&amp;rft_id=info%3Apmid%2F20856790&amp;rft.jtitle=OncoTargets+and+therapy&amp;rft.pages=157-65&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Soiffer2008-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Soiffer2008_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Soiffer2008_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Robert J. Soiffer (17 November 2008). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=8kdFhqeZO10C"><i>Hematopoietic Stem Cell Transplantation</i></a>. Springer. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-934115-05-3" title="Special:BookSources/978-1-934115-05-3">978-1-934115-05-3</a><span class="reference-accessdate">. Retrieved <span class="nowrap">23 September</span> 2012</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.aulast=Robert+J.+Soiffer&amp;rft.au=Robert+J.+Soiffer&amp;rft.btitle=Hematopoietic+Stem+Cell+Transplantation&amp;rft.date=17+November+2008&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D8kdFhqeZO10C&amp;rft.isbn=978-1-934115-05-3&amp;rft.pub=Springer&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12057067-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid12057067_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12057067_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid12057067_6-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bennett, JM (June 2002). "Chronic myelomonocytic leukemia". <i>Current treatment options in oncology</i> <b>3</b> (3): 221–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs11864-002-0011-6">10.1007/s11864-002-0011-6</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12057067">12057067</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Chronic+myelomonocytic+leukemia&amp;rft.au=Bennett%2C+JM&amp;rft.aufirst=JM&amp;rft.aulast=Bennett&amp;rft.date=June+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs11864-002-0011-6&amp;rft_id=info%3Apmid%2F12057067&amp;rft.issue=3&amp;rft.jtitle=Current+treatment+options+in+oncology&amp;rft.pages=221-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn4051-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-isbn4051_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-isbn4051_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-isbn4051_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-isbn4051_7-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-isbn4051_7-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Bain, Barbara J. (2003). <i>Leukaemia Diagnosis</i>. Cambridge, MA: Blackwell Publishers. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-4051-0661-1" title="Special:BookSources/1-4051-0661-1">1-4051-0661-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.au=Bain%2C+Barbara+J.&amp;rft.aulast=Bain%2C+Barbara+J.&amp;rft.btitle=Leukaemia+Diagnosis&amp;rft.date=2003&amp;rft.genre=book&amp;rft.isbn=1-4051-0661-1&amp;rft.place=Cambridge%2C+MA&amp;rft.pub=Blackwell+Publishers&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20699489-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20699489_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20699489_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bhargava R, Dalal BI (2010). "Two steps forward, one step back: 4th WHO classification of myeloid neoplasms (2008)". <i>Indian J Pathol Microbiol</i> <b>53</b> (3): 391–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4103%2F0377-4929.68240">10.4103/0377-4929.68240</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20699489">20699489</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Two+steps+forward%2C+one+step+back%3A+4th+WHO+classification+of+myeloid+neoplasms+%282008%29&amp;rft.au=Bhargava+R%2C+Dalal+BI&amp;rft.aulast=Bhargava+R%2C+Dalal+BI&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.4103%2F0377-4929.68240&amp;rft_id=info%3Apmid%2F20699489&amp;rft.issue=3&amp;rft.jtitle=Indian+J+Pathol+Microbiol&amp;rft.pages=391-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn85623-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn85623_9-0">^</a></b></span> <span class="reference-text"><span class="citation book">Turgeon, Mary Louise (1999). <i>Clinical hematology: theory and procedures</i>. Hagerstwon, MD: Lippincott Williams &amp; Wilkins. pp.&#160;321–322. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-316-85623-1" title="Special:BookSources/0-316-85623-1">0-316-85623-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.aulast=Turgeon%2C+Mary+Louise&amp;rft.au=Turgeon%2C+Mary+Louise&amp;rft.btitle=Clinical+hematology%3A+theory+and+procedures&amp;rft.date=1999&amp;rft.genre=book&amp;rft.isbn=0-316-85623-1&amp;rft.pages=321-322&amp;rft.place=Hagerstwon%2C+MD&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn0123744199-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn0123744199_10-0">^</a></b></span> <span class="reference-text"><span class="citation book">Tsongalis, Gregory J.; Coleman, William L. (2009). <i>MOLECULAR PATHOLOGY: THE MOLECULAR BASIS OF HUMAN DISEASE; ED. BY WILLIAM B. COLEMAN</i>. Amsterdam: Elsevier Academic Press. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-12-374419-9" title="Special:BookSources/0-12-374419-9">0-12-374419-9</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.aulast=Tsongalis%2C+Gregory+J.%3B+Coleman%2C+William+L.&amp;rft.au=Tsongalis%2C+Gregory+J.%3B+Coleman%2C+William+L.&amp;rft.btitle=MOLECULAR+PATHOLOGY%3A+THE+MOLECULAR+BASIS+OF+HUMAN+DISEASE%3B+ED.+BY+WILLIAM+B.+COLEMAN&amp;rft.date=2009&amp;rft.genre=book&amp;rft.isbn=0-12-374419-9&amp;rft.place=Amsterdam&amp;rft.pub=Elsevier+Academic+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid22160044-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22160044_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22160044_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid22160044_11-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid22160044_11-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid22160044_11-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid22160044_11-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid22160044_11-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Cazzola M, Malcovati L, Invernizzi R (2011). "Myelodysplastic/myeloproliferative neoplasms". <i>Hematology Am Soc Hematol Educ Program</i> <b>2011</b>: 264–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fasheducation-2011.1.264">10.1182/asheducation-2011.1.264</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22160044">22160044</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Myelodysplastic%2Fmyeloproliferative+neoplasms&amp;rft.au=Cazzola+M%2C+Malcovati+L%2C+Invernizzi+R&amp;rft.aulast=Cazzola+M%2C+Malcovati+L%2C+Invernizzi+R&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2011.1.264&amp;rft_id=info%3Apmid%2F22160044&amp;rft.jtitle=Hematology+Am+Soc+Hematol+Educ+Program&amp;rft.pages=264-72&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2011" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn2411-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-isbn2411_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-isbn2411_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-isbn2411_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-isbn2411_12-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-isbn2411_12-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation book"><i>Pathology and Genetics of Haemo (World Health Organization Classification of Tumours S.)</i>. Oxford Univ Pr. 2003. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/92-832-2411-6" title="Special:BookSources/92-832-2411-6">92-832-2411-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.btitle=Pathology+and+Genetics+of+Haemo+%28World+Health+Organization+Classification+of+Tumours+S.%29&amp;rft.date=2003&amp;rft.genre=book&amp;rft.isbn=92-832-2411-6&amp;rft.pub=Oxford+Univ+Pr&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn79891-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-isbn79891_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-isbn79891_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-isbn79891_13-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-isbn79891_13-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Viktoria Faber; Richard Greil; Lisa Pleyer; Daniel Neureiter (2010). <i>Chronic Myeloid Neoplasias and Clonal Overlap Syndromes: Epidemiology, Pathophysiology and Treatment Options</i>. Berlin: Springer. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/3-211-79891-9" title="Special:BookSources/3-211-79891-9">3-211-79891-9</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.aulast=Viktoria+Faber%3B+Richard+Greil%3B+Lisa+Pleyer%3B+Daniel+Neureiter&amp;rft.au=Viktoria+Faber%3B+Richard+Greil%3B+Lisa+Pleyer%3B+Daniel+Neureiter&amp;rft.btitle=Chronic+Myeloid+Neoplasias+and+Clonal+Overlap+Syndromes%3A+Epidemiology%2C+Pathophysiology+and+Treatment+Options&amp;rft.date=2010&amp;rft.genre=book&amp;rft.isbn=3-211-79891-9&amp;rft.place=Berlin&amp;rft.pub=Springer&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn9890-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-isbn9890_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-isbn9890_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Paul Moss; Victor Hoffbrand (2011). <i>Essential Haematology, Includes FREE Desktop Edition (Essentials)</i>. Wiley-Blackwell. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-4051-9890-7" title="Special:BookSources/1-4051-9890-7">1-4051-9890-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.aulast=Paul+Moss%3B+Victor+Hoffbrand&amp;rft.au=Paul+Moss%3B+Victor+Hoffbrand&amp;rft.btitle=Essential+Haematology%2C+Includes+FREE+Desktop+Edition+%28Essentials%29&amp;rft.date=2011&amp;rft.genre=book&amp;rft.isbn=1-4051-9890-7&amp;rft.pub=Wiley-Blackwell&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn7817-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn7817_15-0">^</a></b></span> <span class="reference-text"><span class="citation book">Hirschmann, Jan V.; Tkachuk, Douglas C.; Wintrobe, Maxwell Myer (2007). <i>Wintrobe's atlas of clinical hematology</i>. Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-7023-8" title="Special:BookSources/0-7817-7023-8">0-7817-7023-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.au=Hirschmann%2C+Jan+V.%3B+Tkachuk%2C+Douglas+C.%3B+Wintrobe%2C+Maxwell+Myer&amp;rft.aulast=Hirschmann%2C+Jan+V.%3B+Tkachuk%2C+Douglas+C.%3B+Wintrobe%2C+Maxwell+Myer&amp;rft.btitle=Wintrobe%27s+atlas+of+clinical+hematology&amp;rft.date=2007&amp;rft.genre=book&amp;rft.isbn=0-7817-7023-8&amp;rft.place=Philadelphia&amp;rft.pub=Wolters+Kluwer+Health%2FLippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn370607-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-isbn370607_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-isbn370607_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Wayne W. Grody; Naeim, Faramarz (2008). <i>Hematopathology: morphology, immunophenotype, cytogenetics, and molecular approaches</i>. Amsterdam: Elsevier/Academic Press. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-12-370607-6" title="Special:BookSources/0-12-370607-6">0-12-370607-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.aulast=Wayne+W.+Grody%3B+Naeim%2C+Faramarz&amp;rft.au=Wayne+W.+Grody%3B+Naeim%2C+Faramarz&amp;rft.btitle=Hematopathology%3A+morphology%2C+immunophenotype%2C+cytogenetics%2C+and+molecular+approaches&amp;rft.date=2008&amp;rft.genre=book&amp;rft.isbn=0-12-370607-6&amp;rft.place=Amsterdam&amp;rft.pub=Elsevier%2FAcademic+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-isbn84214-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn84214_17-0">^</a></b></span> <span class="reference-text"><span class="citation book">Foxwell Nathan Emmons; Wojciech Gorczyca; James Weisberger (2004). <i>An Atlas of Differential Diagnosis in Neoplastic Hematopathology</i>. Washington, DC: Taylor &amp; Francis. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-84214-247-X" title="Special:BookSources/1-84214-247-X">1-84214-247-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.au=Foxwell+Nathan+Emmons%3B+Wojciech+Gorczyca%3B+James+Weisberger&amp;rft.aulast=Foxwell+Nathan+Emmons%3B+Wojciech+Gorczyca%3B+James+Weisberger&amp;rft.btitle=An+Atlas+of+Differential+Diagnosis+in+Neoplastic+Hematopathology&amp;rft.date=2004&amp;rft.genre=book&amp;rft.isbn=1-84214-247-X&amp;rft.place=Washington%2C+DC&amp;rft.pub=Taylor+%26+Francis&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid6952920-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid6952920_18-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bennett JM, Catovsky D, Daniel MT et al. (June 1982). "Proposals for the classification of the myelodysplastic syndromes". <i>Br. J. Haematol.</i> <b>51</b> (2): 189–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2141.1982.tb02771.x">10.1111/j.1365-2141.1982.tb02771.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6952920">6952920</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Proposals+for+the+classification+of+the+myelodysplastic+syndromes&amp;rft.au=Bennett+JM%2C+Catovsky+D%2C+Daniel+MT&amp;rft.aulast=Bennett+JM%2C+Catovsky+D%2C+Daniel+MT&amp;rft.date=June+1982&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.1982.tb02771.x&amp;rft_id=info%3Apmid%2F6952920&amp;rft.issue=2&amp;rft.jtitle=Br.+J.+Haematol.&amp;rft.pages=189-99&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12446429-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12446429_19-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Arceci RJ, Longley BJ, Emanuel PD (2002). "Atypical cellular disorders". <i>Hematology Am Soc Hematol Educ Program</i> <b>2002</b>: 297–314. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fasheducation-2002.1.297">10.1182/asheducation-2002.1.297</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12446429">12446429</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Atypical+cellular+disorders&amp;rft.au=Arceci+RJ%2C+Longley+BJ%2C+Emanuel+PD&amp;rft.aulast=Arceci+RJ%2C+Longley+BJ%2C+Emanuel+PD&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2002.1.297&amp;rft_id=info%3Apmid%2F12446429&amp;rft.jtitle=Hematology+Am+Soc+Hematol+Educ+Program&amp;rft.pages=297-314&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2002" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-FinnPeterson2004-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-FinnPeterson2004_20-0">^</a></b></span> <span class="reference-text"><span class="citation book">William G. Finn; LoAnn C. Peterson (31 May 2004). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=3Y82zWON-kkC&amp;pg=PA33"><i>Hematopathology in Oncology</i></a>. Springer. pp.&#160;33–. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4020-7919-1" title="Special:BookSources/978-1-4020-7919-1">978-1-4020-7919-1</a><span class="reference-accessdate">. Retrieved <span class="nowrap">23 September</span> 2012</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.aulast=William+G.+Finn&amp;rft.au=LoAnn+C.+Peterson&amp;rft.au=William+G.+Finn&amp;rft.btitle=Hematopathology+in+Oncology&amp;rft.date=31+May+2004&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D3Y82zWON-kkC%26pg%3DPA33&amp;rft.isbn=978-1-4020-7919-1&amp;rft.pages=33-&amp;rft.pub=Springer&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Bain2003-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bain2003_21-0">^</a></b></span> <span class="reference-text"><span class="citation book">Barbara J. Bain (2003). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=ynOZ0iD4NFgC&amp;pg=PA72"><i>Chronic Myeloproliferative Disorders: Cytogenetic and Molecular Genetic Abnormalities</i></a>. Karger Publishers. pp.&#160;72–. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-8055-7307-8" title="Special:BookSources/978-3-8055-7307-8">978-3-8055-7307-8</a><span class="reference-accessdate">. Retrieved <span class="nowrap">23 September</span> 2012</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.au=Barbara+J.+Bain&amp;rft.aulast=Barbara+J.+Bain&amp;rft.btitle=Chronic+Myeloproliferative+Disorders%3A+Cytogenetic+and+Molecular+Genetic+Abnormalities&amp;rft.date=2003&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DynOZ0iD4NFgC%26pg%3DPA72&amp;rft.isbn=978-3-8055-7307-8&amp;rft.pages=72-&amp;rft.pub=Karger+Publishers&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9058730-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9058730_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Greenberg P, Cox C, LeBeau MM et al. (March 1997). "International scoring system for evaluating prognosis in myelodysplastic syndromes". <i>Blood</i> <b>89</b> (6): 2079–88. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9058730">9058730</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=International+scoring+system+for+evaluating+prognosis+in+myelodysplastic+syndromes&amp;rft.au=Greenberg+P%2C+Cox+C%2C+LeBeau+MM&amp;rft.aulast=Greenberg+P%2C+Cox+C%2C+LeBeau+MM&amp;rft.date=March+1997&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F9058730&amp;rft.issue=6&amp;rft.jtitle=Blood&amp;rft.pages=2079-88&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=89" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21239815-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21239815_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Garcia-Manero G (2010). "Prognosis of myelodysplastic syndromes". <i>Hematology Am Soc Hematol Educ Program</i> <b>2010</b>: 330–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fasheducation-2010.1.330">10.1182/asheducation-2010.1.330</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21239815">21239815</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Prognosis+of+myelodysplastic+syndromes&amp;rft.au=Garcia-Manero+G&amp;rft.aulast=Garcia-Manero+G&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2010.1.330&amp;rft_id=info%3Apmid%2F21239815&amp;rft.jtitle=Hematology+Am+Soc+Hematol+Educ+Program&amp;rft.pages=330-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2010" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11806985-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11806985_24-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Onida F, Kantarjian HM, Smith TL et al. (February 2002). "Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients". <i>Blood</i> <b>99</b> (3): 840–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood.V99.3.840">10.1182/blood.V99.3.840</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11806985">11806985</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Prognostic+factors+and+scoring+systems+in+chronic+myelomonocytic+leukemia%3A+a+retrospective+analysis+of+213+patients&amp;rft.aulast=Onida+F%2C+Kantarjian+HM%2C+Smith+TL&amp;rft.au=Onida+F%2C+Kantarjian+HM%2C+Smith+TL&amp;rft.date=February+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.V99.3.840&amp;rft_id=info%3Apmid%2F11806985&amp;rft.issue=3&amp;rft.jtitle=Blood&amp;rft.pages=840-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=99" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21401573-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21401573_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bacher U, Haferlach T, Schnittger S, Kreipe H, Kröger N (March 2011). "Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia". <i>Br J Haematol</i> <b>153</b> (2): 149–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2141.2011.08631.x">10.1111/j.1365-2141.2011.08631.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21401573">21401573</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelomonocytic+leukemia&amp;rft.atitle=Recent+advances+in+diagnosis%2C+molecular+pathology+and+therapy+of+chronic+myelomonocytic+leukaemia&amp;rft.au=Bacher+U%2C+Haferlach+T%2C+Schnittger+S%2C+Kreipe+H%2C+Kr%C3%B6ger+N&amp;rft.aulast=Bacher+U%2C+Haferlach+T%2C+Schnittger+S%2C+Kreipe+H%2C+Kr%C3%B6ger+N&amp;rft.date=March+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.2011.08631.x&amp;rft_id=info%3Apmid%2F21401573&amp;rft.issue=2&amp;rft.jtitle=Br+J+Haematol&amp;rft.pages=149-67&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=153" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Myeloid_malignancy" title="Template:Myeloid malignancy"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Myeloid_malignancy" title="Template talk:Myeloid malignancy"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Myeloid_malignancy&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Myeloid" title="Myeloid">Myeloid</a> <a href="/wiki/Hematological_malignancy" title="Hematological malignancy" class="mw-redirect">hematological malignancy</a>/<a href="/wiki/Leukemia" title="Leukemia">leukemia</a> histology (<a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a> 9590–9989, <a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C81.E2.80.93C96.29_Malignant_neoplasms.2C_stated_or_presumed_to_be_primary.2C_of_lymphoid.2C_haematopoietic_and_related_tissue" title="ICD-10 Chapter II: Neoplasms">C81–C96</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_lymphatic_and_hematopoietic_tissue_.28200.E2.80.93208.29" title="List of ICD-9 codes 140–239: neoplasms">200–208</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-GM" title="CFU-GM">CFU-GM</a>/<br />
and other <a href="/wiki/Granulocyte" title="Granulocyte">granulocytes</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-GM" title="CFU-GM">CFU-GM</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Myelocyte" title="Myelocyte">Myelocyte</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a>:</i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_myeloblastic_leukemia" title="Acute myeloblastic leukemia">Acute myeloblastic leukemia</a></li>
<li><a href="/wiki/Minimally_differentiated_acute_myeloblastic_leukemia" title="Minimally differentiated acute myeloblastic leukemia">M0</a></li>
<li><a href="/wiki/Acute_myeloblastic_leukemia_without_maturation" title="Acute myeloblastic leukemia without maturation">M1</a></li>
<li><a href="/wiki/Acute_myeloblastic_leukemia_with_maturation" title="Acute myeloblastic leukemia with maturation">M2</a></li>
<li><a href="/wiki/Acute_promyelocytic_leukemia" title="Acute promyelocytic leukemia">APL/M3</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Chronic_neutrophilic_leukemia" title="Chronic neutrophilic leukemia">Chronic neutrophilic leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Monocyte" title="Monocyte">Monocyte</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_monocytic_leukemia" title="Acute monocytic leukemia">AMoL/M5</a></li>
<li><a href="/wiki/Acute_myeloid_dendritic_cell_leukemia" title="Acute myeloid dendritic cell leukemia">Myeloid dendritic cell leukemia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Chronic_myelogenous_leukemia" title="Chronic myelogenous leukemia">CML</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a></li>
<li><a href="/wiki/Accelerated_phase_chronic_myelogenous_leukemia" title="Accelerated phase chronic myelogenous leukemia">Accelerated phase chronic myelogenous leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Myelomonocyte" title="Myelomonocyte">Myelomonocyte</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_myelomonocytic_leukemia" title="Acute myelomonocytic leukemia">M4</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myelodysplastic%E2%80%93myeloproliferative_diseases" title="Myelodysplastic–myeloproliferative diseases">MD-MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Juvenile_myelomonocytic_leukemia" title="Juvenile myelomonocytic leukemia">Juvenile myelomonocytic leukemia</a></li>
<li><strong class="selflink">Chronic myelomonocytic leukemia</strong></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Histiocytosis" title="Histiocytosis">Histiocytosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-Baso" title="CFU-Baso">CFU-Baso</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_basophilic_leukemia" title="Acute basophilic leukemia">Acute basophilic</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-Eos" title="CFU-Eos">CFU-Eos</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_eosinophilic_leukemia" title="Acute eosinophilic leukemia">Acute eosinophilic</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Chronic_eosinophilic_leukemia" title="Chronic eosinophilic leukemia">Chronic eosinophilic leukemia</a>/<a href="/wiki/Hypereosinophilic_syndrome" title="Hypereosinophilic syndrome">Hypereosinophilic syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Megakaryocyte%E2%80%93erythroid_progenitor_cell" title="Megakaryocyte–erythroid progenitor cell">MEP</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-Meg" title="CFU-Meg">CFU-Meg</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_megakaryoblastic_leukemia" title="Acute megakaryoblastic leukemia">AMKL/M7</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Essential_thrombocytosis" title="Essential thrombocytosis" class="mw-redirect">Essential thrombocytosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-E" title="CFU-E">CFU-E</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_erythroid_leukemia" title="Acute erythroid leukemia">Erythroleukemia/M6</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Polycythemia_vera" title="Polycythemia vera">Polycythemia vera</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myelodysplastic_syndrome" title="Myelodysplastic syndrome">MD</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Anemia" title="Anemia">Refractory anemia</a></li>
<li><a href="/wiki/Refractory_anemia_with_excess_of_blasts" title="Refractory anemia with excess of blasts">Refractory anemia with excess of blasts</a></li>
<li><a href="/wiki/Chromosome_5q_deletion_syndrome" title="Chromosome 5q deletion syndrome">Chromosome 5q deletion syndrome</a></li>
<li><a href="/wiki/Sideroblastic_anemia" title="Sideroblastic anemia">Sideroblastic anemia</a></li>
<li><a href="/wiki/Paroxysmal_nocturnal_hemoglobinuria" title="Paroxysmal nocturnal hemoglobinuria">Paroxysmal nocturnal hemoglobinuria</a></li>
<li><a href="/wiki/Refractory_cytopenia_with_multilineage_dysplasia" title="Refractory cytopenia with multilineage dysplasia">Refractory cytopenia with multilineage dysplasia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-Mast" title="CFU-Mast">CFU-Mast</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Mastocytoma" title="Mastocytoma">Mastocytoma</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Mast_cell_leukemia" title="Mast cell leukemia">Mast cell leukemia</a></li>
<li><a href="/wiki/Mast_cell_sarcoma" title="Mast cell sarcoma">Mast cell sarcoma</a></li>
<li><a href="/wiki/Mastocytosis" title="Mastocytosis">Systemic mastocytosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><a href="/wiki/Mastocytosis" title="Mastocytosis">Mastocytosis</a>:</span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diffuse_cutaneous_mastocytosis" title="Diffuse cutaneous mastocytosis">Diffuse cutaneous mastocytosis</a></li>
<li><a href="/wiki/Erythrodermic_mastocytosis" title="Erythrodermic mastocytosis">Erythrodermic mastocytosis</a></li>
<li><a href="/wiki/Adult_type_of_generalized_eruption_of_cutaneous_mastocytosis" title="Adult type of generalized eruption of cutaneous mastocytosis">Adult type of generalized eruption of cutaneous mastocytosis</a></li>
<li><a href="/wiki/Urticaria_pigmentosa" title="Urticaria pigmentosa">Urticaria pigmentosa</a></li>
<li><a href="/wiki/Mast_cell_sarcoma" title="Mast cell sarcoma">Mast cell sarcoma</a></li>
<li><a href="/wiki/Solitary_mastocytoma" title="Solitary mastocytoma">Solitary mastocytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;">Systemic mastocytosis</span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Xanthelasmoidal_mastocytosis" title="Xanthelasmoidal mastocytosis">Xanthelasmoidal mastocytosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Multiple/unknown</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_panmyelosis_with_myelofibrosis" title="Acute panmyelosis with myelofibrosis">Acute panmyelosis with myelofibrosis</a></li>
<li><a href="/wiki/Myeloid_sarcoma" title="Myeloid sarcoma">Myeloid sarcoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Myelofibrosis" title="Myelofibrosis">Myelofibrosis</a></li>
<li><a href="/wiki/Acute_biphenotypic_leukaemia" title="Acute biphenotypic leukaemia">Acute biphenotypic leukaemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Myeloid_navs" title="Template:Myeloid navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Myeloid_navs" title="Template talk:Myeloid navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Myeloid_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Myeloid" title="Myeloid">cells from bone marrow</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Myeloid_innate_immune_system" title="Template:Myeloid innate immune system">Immune system</a></li>
<li><a href="/wiki/Template:Myeloid_blood_cells_and_plasma" title="Template:Myeloid blood cells and plasma">Cells</a></li>
<li><a href="/wiki/Template:Myeloid_physiology" title="Template:Myeloid physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Coagulation" title="Template:Coagulation">coagulation</a></li>
<li><a href="/wiki/Template:Hemeproteins" title="Template:Hemeproteins">proteins</a></li>
<li><a href="/wiki/Template:Granule_contents" title="Template:Granule contents">granule contents</a></li>
<li><a href="/wiki/Template:Colony-stimulating_factors" title="Template:Colony-stimulating factors">colony-stimulating</a></li>
<li>heme and porphyrin
<ul>
<li><i><a href="/wiki/Template:Porphyrin_metabolism_enzymes" title="Template:Porphyrin metabolism enzymes">metabolism</a></i></li>
<li><i><a href="/wiki/Template:Heme_metabolism_intermediates" title="Template:Heme metabolism intermediates">intermediates</a></i></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Diseases_of_RBCs_and_megakaryocytes" title="Template:Diseases of RBCs and megakaryocytes">Red blood cell</a></li>
<li><a href="/wiki/Template:Monocyte_and_granulocyte_disease" title="Template:Monocyte and granulocyte disease">Monocyte and granulocyte</a></li>
<li><a href="/wiki/Template:Myeloid_malignancy" title="Template:Myeloid malignancy">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Histiocytosis" title="Template:Histiocytosis">Histiocytosis</a></li>
<li><a href="/wiki/Template:Cardiovascular_system_symptoms_and_signs" title="Template:Cardiovascular system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_hematology" title="Template:Eponymous medical signs for hematology">eponymous</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Myeloid_blood_tests" title="Template:Myeloid blood tests">Blood tests</a>
<ul>
<li><a href="/wiki/Template:Abnormal_clinical_and_laboratory_findings_for_blood" title="Template:Abnormal clinical and laboratory findings for blood">findings</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Transfusion_medicine" title="Template:Transfusion medicine">Transfusion</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antithrombotics" title="Template:Antithrombotics">thrombosis</a></li>
<li><a href="/wiki/Template:Antihemorrhagics" title="Template:Antihemorrhagics">bleeding</a></li>
<li><a href="/wiki/Template:B03,_B05,_B06" title="Template:B03, B05, B06">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1163
CPU time usage: 0.464 seconds
Real time usage: 0.541 seconds
Preprocessor visited node count: 2602/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 153238/2097152 bytes
Template argument size: 1072/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/500
Lua time usage: 0.162/10.000 seconds
Lua memory usage: 3.08 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  411.203      1 - -total
 43.76%  179.952     14 - Template:Navbox
 40.95%  168.390      1 - Template:Reflist
 24.78%  101.898      1 - Template:Infobox_disease
 23.06%   94.840      1 - Template:Myeloid_malignancy
 21.85%   89.837      1 - Template:Infobox
 18.12%   74.498     13 - Template:Cite_journal
  9.07%   37.278     12 - Template:Cite_book
  6.44%   26.477      1 - Template:Myeloid_navs
  4.32%   17.780      1 - Template:Comma_separated_entries
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:8072180-0!*!0!!en!4!* and timestamp 20150712021033 and revision id 668628283
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;oldid=668628283">https://en.wikipedia.org/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;oldid=668628283</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Chronic_myeloid_leukemia" title="Category:Chronic myeloid leukemia">Chronic myeloid leukemia</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Chronic+myelomonocytic+leukemia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Chronic+myelomonocytic+leukemia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Chronic_myelomonocytic_leukemia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Chronic_myelomonocytic_leukemia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Chronic_myelomonocytic_leukemia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Chronic_myelomonocytic_leukemia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Chronic_myelomonocytic_leukemia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;oldid=668628283" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1088072" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Chronic_myelomonocytic_leukemia&amp;id=668628283" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Chronic+myelomonocytic+leukemia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Chronic+myelomonocytic+leukemia&amp;oldid=668628283&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Chronische_myelomonozyt%C3%A4re_Leuk%C3%A4mie" title="Chronische myelomonozytäre Leukämie – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/L%C4%97tin%C4%97_mielomonocitin%C4%97_leukemija" title="Lėtinė mielomonocitinė leukemija – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E6%85%A2%E6%80%A7%E9%AA%A8%E9%AB%84%E5%8D%98%E7%90%83%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85" title="慢性骨髄単球性白血病 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1088072#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 25 June 2015, at 15:31.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Chronic_myelomonocytic_leukemia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":662,"wgHostname":"mw1163"});
}</script>
	</body>
</html>
